ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1448

Single-cell RNA Sequencing of Livedo Reticularis Skin Reveals Endothelial Pathology in Antiphospholipid Syndrome

Hui Shi1, Allison Billi1, Rachael Wasikowski1, Kelsey Gockman1, Alex Tsoi1, Johann Gudjonsson2 and Jason Knight3, 1University of Michigan, Ann Arbor, 2University of Michigan, Ann ArborUniversity of Michigan, 3Division of Rheumatology, University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2020

Keywords: antiphospholipid syndrome, Gene Expression

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Antiphospholipid Syndrome (1447–1451)

Session Type: Abstract Session

Session Time: 4:00PM-4:50PM

Background/Purpose: Antiphospholipid syndrome (APS) is a thromboinflammatory disease that can present with a variety of clinical phenotypes. Livedo reticularis is the most common skin manifestation of APS, representing a netlike pattern of reddish-blue skin discoloration indicative of superficial vessels that have swollen in response to sluggish flow in the deeper vascular network. Interestingly, livedo reticularis is predictive of APS patients at higher risk of cerebrovascular events. Although the interaction between antiphospholipid antibodies (aPL) and endothelial cells are likely key mechanistic drivers of livedo reticularis, these cells have rarely been directly studied. Here, we used single-cell RNA sequencing to begin to characterize APS endothelial cells.

Methods: We applied single-cell RNA sequencing to skin biopsies of two APS patients with livedo reticularis and three matched controls with neither APS nor livedo; t-distributed stochastic neighbor embedding (t-SNE) was then used to identify the various cell types. We performed GO and pathway enrichment by using Database for Annotation, Visualization, and Integrated Discovery (DAVID) analysis.

Results: By combining the t-SNE analysis with the expression of known endothelial cell markers, we identified three subpopulations of endothelial cells among the sorted cells (Figure 1). Subsequently, we compared expression profiles between endothelial cells from healthy and APS skin and found significant upregulation of CD36 (a scavenger receptor) and TXNIP (a mediator of oxidative stress) in APS endothelial cells. Using DAVID analysis, we revealed that the APS endothelial cell expression profile is enriched for processes associated with cell adhesion, angiogenesis, and type I interferon signaling.

Conclusion: To our knowledge, this is the first direct analysis of gene expression in APS endothelial cells. These data suggest that APS endothelial cells from skin affected by livedo reticularis demonstrate a pattern of gene expression associated with endothelial activation and damage. We are actively recruiting additional patients into the study in pursuit of providing a foundation for future studies of vascular injury in APS.

Figure 1 t-SNE analysis of the cells isolated from the antiphospholipid syndrome (APS) skin with livedo reticularis. Defined number of 13 clusters with every cluster represented by a different color.


Disclosure: H. Shi, None; A. Billi, None; R. Wasikowski, None; K. Gockman, None; A. Tsoi, None; J. Gudjonsson, Celgene, 2; J. Knight, None.

To cite this abstract in AMA style:

Shi H, Billi A, Wasikowski R, Gockman K, Tsoi A, Gudjonsson J, Knight J. Single-cell RNA Sequencing of Livedo Reticularis Skin Reveals Endothelial Pathology in Antiphospholipid Syndrome [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/single-cell-rna-sequencing-of-livedo-reticularis-skin-reveals-endothelial-pathology-in-antiphospholipid-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-rna-sequencing-of-livedo-reticularis-skin-reveals-endothelial-pathology-in-antiphospholipid-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology